-
1 Comment
Zimmer Biomet Holdings, Inc is currently in a long term uptrend where the price is trading 1.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.8.
Zimmer Biomet Holdings, Inc's total revenue sank by 99.7% to $7M since the same quarter in the previous year.
Its net income has dropped by 100.0% to $-137K since the same quarter in the previous year.
Finally, its free cash flow fell by 333.6% to $-868M since the same quarter in the previous year.
Based on the above factors, Zimmer Biomet Holdings, Inc gets an overall score of 2/5.
Exchange | NYSE |
---|---|
CurrencyCode | USD |
ISIN | US98956P1021 |
Sector | Healthcare |
Industry | Medical Devices |
Beta | 0.84 |
---|---|
Market Cap | 20B |
PE Ratio | 23.11 |
Target Price | 122.3504 |
Dividend Yield | 0.8% |
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ZBH using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025